When HCC patients were compared with CLD and LC patients, the AUC for thioredoxin was larger than that for AFP (0.854, 0.812–0.903 vs. 0.729, 0.684–0.838, P < 0.0001; Table 3). This evidence concerns the gene TXN and hepatocellular carcinoma.